Fig 3. Dependency of findings on vaccine hesitancy.

(A) For different levels of vaccine hesitancy (30%, 20%, 10%, 0%), the optimal vaccine allocation strategies with respect to three objectives (top row) are shown, in addition to the CDC allocation. Sub-populations 1–17 are defined as in Table 2. (B-D) Comparison of outcomes (total deaths (B), years of life lost (C) and total cases (D)) when using the respective optimal allocation strategy from (A; black line) and the CDC strategy (red line), for any vaccine hesitancy between 0% and 30%. The background color indicates which of the allocation strategies, identified in (A; bottom row), was optimal for a specific level of hesitancy.